Alembic
ALEMBICLTD
₹ 88.50
₹ 2.15
2.48%
Alembic Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | - | - |
| Weekly | -3.38% | 16,36,486 |
| Monthly | -8.10% | 84,78,551 |
Alembic Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| ALEMBICLTD | - | -3.38% | -8.10% |
| Index | - | -1.46% | -2.67% |
| Peer Avg. | - | -3.09% | -0.56% |
*Avg of index constituents
Alembic Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| ALEMBICLTD | 15.02 | 1.29 | 20.46 | 6.45 | 7.35 | 2.53 |
| Index | 36.20 | 6.77 | 17.25 | 17.89 | 19.69 | 1.20 |
| Peer Avg. | 40.04 | 4.96 | 12.35 | 14.74 | 18.51 | 0.87 |
*Avg of index constituents
Alembic Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 5.74% | 532.06% | 6.45 | 7.35 |
| FY '20-21 | -1.22% | -85.42% | 1.39 | 1.75 |
| FY '19-20 | -40.39% | 127.02% | 13.99 | 14.05 |
Alembic Shareholding Pattern
Promoters : 70.88%
FII : 1.12%
DII : 4.69%
Public : 23.31%
Others : 0%
Alembic Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 77.10 | 63.67 | 102.56 | 85.95 |
| FY '20-21 | 72.91 | 62.65 | 21.02 | 13.60 |
| FY '19-20 | 73.81 | 70.45 | 96.93 | 93.29 |
All values are in crores
Alembic Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| ALEMBICLTD | 77.10 | 63.67 | 102.56 | 85.95 |
| MAYURUNIQ | 643.71 | 524.16 | 140 | 89.35 |
| GOKULAGRO | 10,304.09 | 10,093.68 | 226.88 | 112.94 |
All values are in crores
Alembic Similar Stocks
Cipla
CIPLA
₹ 1,339.55
- ₹ 19.25
-1.41%
Dr. Reddy's Laboratories
DRREDDY
₹ 5,921.00
₹ 43.65
0.74%
Lupin
LUPIN
₹ 1,608.55
₹ 24.60
1.55%
Torrent Pharmaceuticals
TORNTPHARM
₹ 2,599.90
₹ 75.55
2.99%
₹ 1,972.30
- ₹ 3.60
-0.18%
Alembic Share Price
Alembic Limited is an Indian company that develops, manufactures and markets pharmaceutical products such as dosage forms and active ingredients. The company operates through one segment, Pharmaceuticals. The Pharmaceutical segment manufactures and markets fermentation and chemical-based active ingredients (API). The company also conducts R&D in Vadodara. The company manufactures/provides three main products/services: Azithromycin, Venlafaxine and Telmisartan.
Alembic FAQs
How to Buy Alembic Share?
To purchase Alembic shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Alembic (ticker symbol: alembicltd) on the trading platform provided by your broker and purchase the shares.
What's Alembic share price today?
The stock price of Alembic as of 10 May 2024 is ₹88.50
What is the Market Cap of Alembic?
Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Alembic (ticker symbol: alembicltd) has a market capitalisation of approximately ₹18,25,71,87,970.80
What is the PE and PB ratio of Alembic?
Alembic Ltd's price-to-book ratio as of 10 May 2024 is 1.2882903, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 15.020473, indicating the market values the company at around ₹15.02 for every ₹1 of earnings
What is the 52 Week High and Low of Alembic Share?
Alembic Ltd (alembicltd) hit its 52-week high at ₹107.65, and its 52-week low at { ₹64.00}.